| 0 |
NEONATAL GASTROINTESTINAL DISORDER |
11 |
0.4074 |
| 1 |
CUTANEOUS ANTHRAX |
1 |
0.2000 |
| 2 |
PENICILLIUM TEST POSITIVE |
1 |
0.2000 |
| 3 |
NEONATAL HYPERGLYCAEMIA |
6 |
0.1622 |
| 4 |
CRYOFIBRINOGENAEMIA |
1 |
0.1250 |
| 5 |
CONGENITAL SYPHILIS |
6 |
0.1132 |
| 6 |
INTRACRANIAL HAEMORRHAGE NEONATAL |
1 |
0.0769 |
| 7 |
MEDIASTINAL ABSCESS |
8 |
0.0615 |
| 8 |
RECALLED PRODUCT ADMINISTERED |
573 |
0.0600 |
| 9 |
EMBOLIA CUTIS MEDICAMENTOSA |
44 |
0.0553 |
| 10 |
PAEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDERS ASSOCIATED WITH STREPTOCOCCAL INFECTION |
1 |
0.0385 |
| 11 |
WOUND CONTAMINATION |
1 |
0.0333 |
| 12 |
NEONATAL RESPIRATORY DEPRESSION |
11 |
0.0331 |
| 13 |
ILEAL ULCER PERFORATION |
1 |
0.0323 |
| 14 |
FOETAL HEART RATE DISORDER |
6 |
0.0311 |
| 15 |
SECONDARY SYPHILIS |
3 |
0.0303 |
| 16 |
BLOOD ALCOHOL ABNORMAL |
1 |
0.0303 |
| 17 |
CHRONIC RHINOSINUSITIS WITH NASAL POLYPS |
4 |
0.0270 |
| 18 |
JARISCH-HERXHEIMER REACTION |
18 |
0.0253 |
| 19 |
DUODENAL ATRESIA |
3 |
0.0244 |
| 20 |
HEPATOSPLENOMEGALY NEONATAL |
1 |
0.0238 |
| 21 |
PHALANGEAL AGENESIS |
1 |
0.0192 |
| 22 |
SYPHILIS |
13 |
0.0179 |
| 23 |
PENILE DERMATITIS |
1 |
0.0159 |
| 24 |
BARTONELLOSIS |
1 |
0.0152 |
| 25 |
CULTURE STOOL POSITIVE |
4 |
0.0146 |
| 26 |
MUSCLE FIBROSIS |
1 |
0.0137 |
| 27 |
KERATOSIS FOLLICULAR |
1 |
0.0128 |
| 28 |
XANTHOGRANULOMA |
1 |
0.0125 |
| 29 |
LIVIDITY |
4 |
0.0109 |
| 30 |
SEGMENTED HYALINISING VASCULITIS |
1 |
0.0098 |
| 31 |
PROPHYLAXIS AGAINST TRANSPLANT REJECTION |
1 |
0.0097 |
| 32 |
ACQUIRED FACTOR V DEFICIENCY |
1 |
0.0091 |
| 33 |
RHEUMATIC HEART DISEASE |
1 |
0.0088 |
| 34 |
BLADDER DISCOMFORT |
11 |
0.0088 |
| 35 |
SPINE MALFORMATION |
3 |
0.0086 |
| 36 |
BACTERIAL TOXAEMIA |
1 |
0.0078 |
| 37 |
VESSEL PERFORATION |
1 |
0.0076 |
| 38 |
ANAL ATRESIA |
4 |
0.0075 |
| 39 |
HYPERADRENOCORTICISM |
2 |
0.0073 |
| 40 |
CANDIDA TEST POSITIVE |
3 |
0.0072 |
| 41 |
URTICARIA CHRONIC |
4 |
0.0071 |
| 42 |
TRICHOMONIASIS |
1 |
0.0069 |
| 43 |
EXTRAPULMONARY TUBERCULOSIS |
2 |
0.0068 |
| 44 |
NEUROSYPHILIS |
1 |
0.0066 |
| 45 |
NAEVUS FLAMMEUS |
1 |
0.0064 |
| 46 |
PHARYNGEAL NEOPLASM |
1 |
0.0064 |
| 47 |
KLEBSIELLA BACTERAEMIA |
6 |
0.0063 |
| 48 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS |
2 |
0.0060 |
| 49 |
OBSTRUCTED LABOUR |
1 |
0.0059 |
| 50 |
PULMONARY NECROSIS |
2 |
0.0059 |
| 51 |
VACCINATION SITE SWELLING |
1 |
0.0058 |
| 52 |
DRUG RESISTANCE MUTATION |
1 |
0.0056 |
| 53 |
IMMUNE-MEDIATED UVEITIS |
1 |
0.0055 |
| 54 |
ENANTHEMA |
3 |
0.0052 |
| 55 |
ARTERIAL SPASM |
1 |
0.0051 |
| 56 |
STRONGYLOIDIASIS |
8 |
0.0049 |
| 57 |
GLOMERULONEPHRITIS ACUTE |
1 |
0.0049 |
| 58 |
OESOPHAGEAL ATRESIA |
3 |
0.0048 |
| 59 |
VACCINATION SITE ERYTHEMA |
1 |
0.0046 |
| 60 |
HISTOLOGY ABNORMAL |
1 |
0.0045 |
| 61 |
OLIGODIPSIA |
1 |
0.0043 |
| 62 |
SJS-TEN OVERLAP |
3 |
0.0043 |
| 63 |
CEREBROVASCULAR INSUFFICIENCY |
1 |
0.0041 |
| 64 |
FEMALE STERILISATION |
2 |
0.0039 |
| 65 |
EXPOSURE TO CONTAMINATED DEVICE |
1 |
0.0038 |
| 66 |
HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION |
1 |
0.0036 |
| 67 |
BACTERIURIA |
2 |
0.0035 |
| 68 |
PALMAR ERYTHEMA |
4 |
0.0035 |
| 69 |
PYOMYOSITIS |
1 |
0.0034 |
| 70 |
RELAPSING MULTIPLE SCLEROSIS |
1 |
0.0033 |
| 71 |
BUTTOCK INJURY |
1 |
0.0033 |
| 72 |
ERYTHROPOIESIS ABNORMAL |
1 |
0.0033 |
| 73 |
INJECTION SITE CELLULITIS |
6 |
0.0032 |
| 74 |
THERAPEUTIC EMBOLISATION |
1 |
0.0032 |
| 75 |
PENILE ULCERATION |
1 |
0.0031 |
| 76 |
VULVOVAGINAL CANDIDIASIS |
4 |
0.0030 |
| 77 |
INJECTION SITE ABSCESS |
7 |
0.0028 |
| 78 |
DRUG-GENETIC INTERACTION |
1 |
0.0028 |
| 79 |
MILIA |
1 |
0.0028 |
| 80 |
HYDROURETER |
1 |
0.0026 |
| 81 |
BONE TUBERCULOSIS |
1 |
0.0026 |
| 82 |
LIMB AMPUTATION |
1 |
0.0025 |
| 83 |
THROMBOCYTOPENIA NEONATAL |
1 |
0.0024 |
| 84 |
GLIOSIS |
1 |
0.0023 |
| 85 |
INFLUENZA A VIRUS TEST POSITIVE |
1 |
0.0023 |
| 86 |
FOETAL GROWTH RESTRICTION |
14 |
0.0023 |
| 87 |
COMPARTMENT SYNDROME |
6 |
0.0023 |
| 88 |
HIP DEFORMITY |
1 |
0.0023 |
| 89 |
EXPIRED DRUG ADMINISTERED |
11 |
0.0022 |
| 90 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
2 |
0.0022 |
| 91 |
ANAEMIA NEONATAL |
1 |
0.0021 |
| 92 |
EAR INJURY |
1 |
0.0020 |
| 93 |
DERMATITIS INFECTED |
1 |
0.0020 |
| 94 |
RETINOPATHY OF PREMATURITY |
1 |
0.0018 |
| 95 |
CHOLESTATIC LIVER INJURY |
4 |
0.0018 |
| 96 |
FEMALE GENITAL TRACT FISTULA |
3 |
0.0018 |
| 97 |
VACCINATION SITE PAIN |
1 |
0.0017 |
| 98 |
ADMINISTRATION SITE PAIN |
2 |
0.0017 |
| 99 |
LIMB REDUCTION DEFECT |
1 |
0.0017 |
| 100 |
PROCALCITONIN INCREASED |
2 |
0.0017 |
| 101 |
CRYSTAL NEPHROPATHY |
1 |
0.0017 |
| 102 |
TOXIC SHOCK SYNDROME |
1 |
0.0016 |
| 103 |
PNEUMONIA NECROTISING |
1 |
0.0015 |
| 104 |
MYELITIS TRANSVERSE |
2 |
0.0014 |
| 105 |
PUBIS FRACTURE |
1 |
0.0014 |
| 106 |
ACCOMMODATION DISORDER |
1 |
0.0014 |
| 107 |
HEART SOUNDS ABNORMAL |
1 |
0.0013 |
| 108 |
CHLAMYDIAL INFECTION |
1 |
0.0013 |
| 109 |
TINEA PEDIS |
2 |
0.0013 |
| 110 |
INFANTILE APNOEA |
1 |
0.0012 |
| 111 |
BRADYCARDIA FOETAL |
1 |
0.0012 |
| 112 |
LYME DISEASE |
4 |
0.0012 |
| 113 |
INJECTION SITE OEDEMA |
2 |
0.0012 |
| 114 |
INCORRECT STORAGE OF DRUG |
2 |
0.0012 |
| 115 |
UPPER AIRWAY OBSTRUCTION |
1 |
0.0011 |
| 116 |
ANOGENITAL WARTS |
1 |
0.0011 |
| 117 |
MUSCLE NECROSIS |
1 |
0.0011 |
| 118 |
ULCERATIVE KERATITIS |
3 |
0.0011 |
| 119 |
COLOUR BLINDNESS |
1 |
0.0011 |
| 120 |
MUSCLE SWELLING |
1 |
0.0011 |
| 121 |
PRODUCT APPEARANCE CONFUSION |
1 |
0.0011 |
| 122 |
MACULE |
3 |
0.0011 |
| 123 |
DELAYED RECOVERY FROM ANAESTHESIA |
1 |
0.0011 |
| 124 |
INJECTION SITE SCAR |
3 |
0.0011 |
| 125 |
HYPOCOAGULABLE STATE |
1 |
0.0010 |
| 126 |
MASTOIDITIS |
1 |
0.0010 |
| 127 |
HYPERAEMIA |
2 |
0.0010 |
| 128 |
DEVICE SAFETY FEATURE ISSUE |
1 |
0.0010 |
| 129 |
ODYNOPHAGIA |
6 |
0.0010 |
| 130 |
ACQUIRED HAEMOPHILIA |
1 |
0.0010 |
| 131 |
HIV INFECTION |
3 |
0.0010 |
| 132 |
SUSPECTED PRODUCT CONTAMINATION |
1 |
0.0010 |
| 133 |
HYPOCHROMIC ANAEMIA |
1 |
0.0010 |
| 134 |
REDUCED FACIAL EXPRESSION |
1 |
0.0010 |
| 135 |
MUSCLE CONTRACTURE |
2 |
0.0010 |
| 136 |
BREAST ABSCESS |
1 |
0.0010 |
| 137 |
POLYHYDRAMNIOS |
1 |
0.0010 |
| 138 |
AXILLARY MASS |
1 |
0.0010 |
| 139 |
BONE DEMINERALISATION |
1 |
0.0009 |
| 140 |
SYRINGE ISSUE |
16 |
0.0009 |
| 141 |
PNEUMONIA STREPTOCOCCAL |
1 |
0.0009 |
| 142 |
PERIRECTAL ABSCESS |
1 |
0.0009 |
| 143 |
MENINGITIS ASEPTIC |
4 |
0.0009 |
| 144 |
BLOODY DISCHARGE |
1 |
0.0009 |
| 145 |
ECCHYMOSIS |
6 |
0.0009 |
| 146 |
PRODUCT CONTAMINATION |
3 |
0.0008 |
| 147 |
PHYSICAL PRODUCT LABEL ISSUE |
1 |
0.0008 |
| 148 |
ERYSIPELAS |
4 |
0.0008 |
| 149 |
VULVOVAGINAL PRURITUS |
4 |
0.0008 |
| 150 |
INCREASED BRONCHIAL SECRETION |
2 |
0.0008 |
| 151 |
SKIN NECROSIS |
4 |
0.0008 |
| 152 |
HYPERSENSITIVITY VASCULITIS |
2 |
0.0008 |
| 153 |
FEELING GUILTY |
1 |
0.0008 |
| 154 |
CALCULUS BLADDER |
1 |
0.0007 |
| 155 |
BILIARY TRACT DISORDER |
1 |
0.0007 |
| 156 |
SERUM SICKNESS |
2 |
0.0007 |
| 157 |
PERIPHERAL ARTERY THROMBOSIS |
1 |
0.0007 |
| 158 |
LIP OEDEMA |
3 |
0.0007 |
| 159 |
CATAPLEXY |
1 |
0.0007 |
| 160 |
TONIC CONVULSION |
1 |
0.0007 |
| 161 |
GLUTEN SENSITIVITY |
1 |
0.0007 |
| 162 |
CEREBELLAR HAEMORRHAGE |
1 |
0.0007 |
| 163 |
DYSPNOEA AT REST |
2 |
0.0007 |
| 164 |
HAEMOTHORAX |
2 |
0.0007 |
| 165 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
1 |
0.0007 |
| 166 |
NORMOCYTIC ANAEMIA |
1 |
0.0007 |
| 167 |
TRANSFUSION |
7 |
0.0007 |
| 168 |
PREMATURE BABY |
20 |
0.0007 |
| 169 |
HYPERCAPNIA |
2 |
0.0007 |
| 170 |
CALCULUS URINARY |
1 |
0.0006 |
| 171 |
NEURITIS |
1 |
0.0006 |
| 172 |
HISTOPLASMOSIS DISSEMINATED |
1 |
0.0006 |
| 173 |
STILLBIRTH |
3 |
0.0006 |
| 174 |
RESPIRATORY ALKALOSIS |
1 |
0.0006 |
| 175 |
INJECTION RELATED REACTION |
1 |
0.0006 |
| 176 |
LINEAR IGA DISEASE |
1 |
0.0006 |
| 177 |
OLIGOHYDRAMNIOS |
2 |
0.0006 |
| 178 |
TONSILLAR HYPERTROPHY |
1 |
0.0006 |
| 179 |
TOXIC ENCEPHALOPATHY |
3 |
0.0006 |
| 180 |
HEPATIC FIBROSIS |
2 |
0.0006 |
| 181 |
PRODUCT CONTAINER SEAL ISSUE |
1 |
0.0006 |
| 182 |
POOR QUALITY PRODUCT ADMINISTERED |
6 |
0.0006 |
| 183 |
NECROTISING FASCIITIS |
2 |
0.0006 |
| 184 |
MITRAL VALVE DISEASE |
1 |
0.0006 |
| 185 |
INDURATION |
1 |
0.0006 |
| 186 |
OBSESSIVE THOUGHTS |
1 |
0.0006 |
| 187 |
INJECTION SITE NODULE |
6 |
0.0005 |
| 188 |
OESOPHAGEAL SPASM |
1 |
0.0005 |
| 189 |
ECONOMIC PROBLEM |
8 |
0.0005 |
| 190 |
NEUROLOGICAL SYMPTOM |
3 |
0.0005 |
| 191 |
OSTEOPOROTIC FRACTURE |
1 |
0.0005 |
| 192 |
CLEFT PALATE |
1 |
0.0005 |
| 193 |
WOUND SECRETION |
2 |
0.0005 |
| 194 |
BICYTOPENIA |
1 |
0.0005 |
| 195 |
UNDERWEIGHT |
1 |
0.0005 |
| 196 |
OESOPHAGEAL PAIN |
2 |
0.0005 |
| 197 |
ANORECTAL DISORDER |
1 |
0.0005 |
| 198 |
FUNGAL SKIN INFECTION |
2 |
0.0005 |
| 199 |
RASH MACULO-PAPULAR |
11 |
0.0005 |
| 200 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
2 |
0.0005 |
| 201 |
INJECTION SITE NECROSIS |
1 |
0.0005 |
| 202 |
TONGUE BITING |
1 |
0.0005 |
| 203 |
HYPOSPADIAS |
1 |
0.0005 |
| 204 |
PHARYNGEAL ERYTHEMA |
1 |
0.0005 |
| 205 |
FOETAL DISTRESS SYNDROME |
1 |
0.0005 |
| 206 |
HYPERPHOSPHATAEMIA |
1 |
0.0005 |
| 207 |
POOR QUALITY DRUG ADMINISTERED |
3 |
0.0005 |
| 208 |
DYSPHEMIA |
2 |
0.0005 |
| 209 |
CORNEAL DISORDER |
1 |
0.0005 |
| 210 |
PARESIS |
1 |
0.0004 |
| 211 |
RHEUMATIC FEVER |
2 |
0.0004 |
| 212 |
PSEUDOMEMBRANOUS COLITIS |
1 |
0.0004 |
| 213 |
SUBSTANCE-INDUCED PSYCHOTIC DISORDER |
1 |
0.0004 |
| 214 |
NEEDLE ISSUE |
13 |
0.0004 |
| 215 |
PRODUCT LABEL ISSUE |
3 |
0.0004 |
| 216 |
COMPUTERISED TOMOGRAM ABNORMAL |
1 |
0.0004 |
| 217 |
BLOOD CHOLESTEROL ABNORMAL |
2 |
0.0004 |
| 218 |
PULSE ABSENT |
2 |
0.0004 |
| 219 |
SUBCUTANEOUS ABSCESS |
2 |
0.0004 |
| 220 |
PREMATURE RUPTURE OF MEMBRANES |
1 |
0.0004 |
| 221 |
SELF ESTEEM DECREASED |
1 |
0.0004 |
| 222 |
HAEMATOLOGICAL INFECTION |
1 |
0.0004 |
| 223 |
COELIAC DISEASE |
4 |
0.0004 |
| 224 |
EYE OEDEMA |
1 |
0.0004 |
| 225 |
PENIS DISORDER |
1 |
0.0004 |
| 226 |
CATHETER SITE HAEMORRHAGE |
1 |
0.0004 |
| 227 |
POOR QUALITY DEVICE USED |
4 |
0.0004 |
| 228 |
PRODUCT CONTAMINATION PHYSICAL |
1 |
0.0004 |
| 229 |
ANGLE CLOSURE GLAUCOMA |
1 |
0.0004 |
| 230 |
HEPATOSPLENOMEGALY |
1 |
0.0004 |
| 231 |
AORTIC ARTERIOSCLEROSIS |
1 |
0.0004 |
| 232 |
BENIGN PROSTATIC HYPERPLASIA |
2 |
0.0004 |
| 233 |
PETECHIAE |
4 |
0.0004 |
| 234 |
PARTIAL SEIZURES |
2 |
0.0004 |
| 235 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
1 |
0.0004 |
| 236 |
ARTERIAL OCCLUSIVE DISEASE |
3 |
0.0004 |
| 237 |
SERUM FERRITIN INCREASED |
2 |
0.0004 |
| 238 |
AGRANULOCYTOSIS |
7 |
0.0004 |
| 239 |
AREFLEXIA |
1 |
0.0004 |
| 240 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
1 |
0.0004 |
| 241 |
OVERWEIGHT |
2 |
0.0004 |
| 242 |
RHINALGIA |
1 |
0.0004 |
| 243 |
RASH MORBILLIFORM |
1 |
0.0004 |
| 244 |
NECROSIS |
2 |
0.0004 |
| 245 |
LIVE BIRTH |
3 |
0.0004 |
| 246 |
SKIN HYPERTROPHY |
1 |
0.0004 |
| 247 |
SKIN PLAQUE |
3 |
0.0004 |
| 248 |
ATYPICAL FEMUR FRACTURE |
1 |
0.0004 |
| 249 |
STATUS EPILEPTICUS |
4 |
0.0004 |
| 250 |
RESPIRATORY SYMPTOM |
1 |
0.0004 |
| 251 |
DERMATITIS CONTACT |
4 |
0.0004 |
| 252 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
6 |
0.0003 |
| 253 |
PARAPLEGIA |
1 |
0.0003 |
| 254 |
ENTEROCOLITIS |
2 |
0.0003 |
| 255 |
METABOLIC DISORDER |
2 |
0.0003 |
| 256 |
ABORTION |
1 |
0.0003 |
| 257 |
ANHEDONIA |
9 |
0.0003 |
| 258 |
INJECTION SITE WARMTH |
7 |
0.0003 |
| 259 |
RESPIRATORY RATE INCREASED |
3 |
0.0003 |
| 260 |
HEPATITIS FULMINANT |
1 |
0.0003 |
| 261 |
BLOOD CULTURE POSITIVE |
1 |
0.0003 |
| 262 |
GANGRENE |
2 |
0.0003 |
| 263 |
CEREBROVASCULAR DISORDER |
1 |
0.0003 |
| 264 |
TOXIC EPIDERMAL NECROLYSIS |
5 |
0.0003 |
| 265 |
DUODENITIS |
1 |
0.0003 |
| 266 |
ECTOPIC PREGNANCY |
1 |
0.0003 |
| 267 |
TESTICULAR PAIN |
1 |
0.0003 |
| 268 |
STEVENS-JOHNSON SYNDROME |
7 |
0.0003 |
| 269 |
CUSHINGOID |
1 |
0.0003 |
| 270 |
STUPOR |
1 |
0.0003 |
| 271 |
INJECTION SITE INDURATION |
4 |
0.0003 |
| 272 |
INJECTION SITE INFECTION |
1 |
0.0003 |
| 273 |
ORAL CANDIDIASIS |
4 |
0.0003 |
| 274 |
IMMUNE SYSTEM DISORDER |
4 |
0.0003 |
| 275 |
INJECTION SITE SWELLING |
23 |
0.0003 |
| 276 |
INJURY ASSOCIATED WITH DEVICE |
6 |
0.0003 |
| 277 |
BRONCHOPNEUMONIA |
1 |
0.0003 |
| 278 |
SKIN LESION |
8 |
0.0003 |
| 279 |
PERIPHERAL COLDNESS |
4 |
0.0003 |
| 280 |
MICTURITION DISORDER |
1 |
0.0003 |
| 281 |
HANGOVER |
1 |
0.0003 |
| 282 |
PAPULE |
2 |
0.0003 |
| 283 |
NEONATAL RESPIRATORY DISTRESS SYNDROME |
1 |
0.0003 |
| 284 |
SKIN WEEPING |
1 |
0.0003 |
| 285 |
APPARENT DEATH |
1 |
0.0003 |
| 286 |
INJECTION SITE HAEMATOMA |
4 |
0.0003 |
| 287 |
LIQUID PRODUCT PHYSICAL ISSUE |
2 |
0.0003 |
| 288 |
DYSSTASIA |
8 |
0.0003 |
| 289 |
ASTHMATIC CRISIS |
1 |
0.0003 |
| 290 |
THROMBOCYTOSIS |
1 |
0.0003 |
| 291 |
VIRAL MUTATION IDENTIFIED |
1 |
0.0003 |
| 292 |
DEVICE BREAKAGE |
11 |
0.0003 |
| 293 |
BLOOD PRESSURE DIASTOLIC DECREASED |
2 |
0.0003 |
| 294 |
HYPERACUSIS |
1 |
0.0003 |
| 295 |
FOETAL EXPOSURE DURING PREGNANCY |
21 |
0.0003 |
| 296 |
PANIC DISORDER |
1 |
0.0003 |
| 297 |
CAESAREAN SECTION |
3 |
0.0003 |
| 298 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
2 |
0.0003 |
| 299 |
PALLOR |
7 |
0.0003 |
| 300 |
APNOEA |
2 |
0.0003 |
| 301 |
VENOUS THROMBOSIS |
1 |
0.0003 |
| 302 |
CYANOSIS |
4 |
0.0003 |
| 303 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
4 |
0.0003 |
| 304 |
PATENT DUCTUS ARTERIOSUS |
1 |
0.0003 |
| 305 |
RENAL CYST |
2 |
0.0003 |
| 306 |
MYOCLONUS |
3 |
0.0003 |
| 307 |
EXPOSURE VIA BREAST MILK |
1 |
0.0003 |
| 308 |
SKIN PAPILLOMA |
1 |
0.0002 |
| 309 |
CYSTITIS HAEMORRHAGIC |
1 |
0.0002 |
| 310 |
INTERNATIONAL NORMALISED RATIO DECREASED |
1 |
0.0002 |
| 311 |
ASPHYXIA |
2 |
0.0002 |
| 312 |
PERIPHERAL ISCHAEMIA |
1 |
0.0002 |
| 313 |
PHARYNGITIS |
3 |
0.0002 |
| 314 |
INJECTION SITE DISCOLOURATION |
3 |
0.0002 |
| 315 |
ANAPHYLACTIC REACTION |
13 |
0.0002 |
| 316 |
ABSCESS LIMB |
1 |
0.0002 |
| 317 |
PURULENT DISCHARGE |
1 |
0.0002 |
| 318 |
MONOPLEGIA |
1 |
0.0002 |
| 319 |
INCORRECT PRODUCT STORAGE |
3 |
0.0002 |
| 320 |
GROIN PAIN |
2 |
0.0002 |
| 321 |
DRUG ERUPTION |
4 |
0.0002 |
| 322 |
MYOSITIS |
2 |
0.0002 |
| 323 |
IRON DEFICIENCY |
1 |
0.0002 |
| 324 |
URINARY TRACT DISORDER |
1 |
0.0002 |
| 325 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 326 |
LEUKOCYTOSIS |
4 |
0.0002 |
| 327 |
ABDOMINAL HERNIA |
1 |
0.0002 |
| 328 |
EAR DISORDER |
1 |
0.0002 |
| 329 |
DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0002 |
| 330 |
INJECTION SITE MASS |
8 |
0.0002 |
| 331 |
CONJUNCTIVITIS |
4 |
0.0002 |
| 332 |
PREGNANCY WITH IMPLANT CONTRACEPTIVE |
1 |
0.0002 |
| 333 |
PRODUCT PACKAGING ISSUE |
2 |
0.0002 |
| 334 |
PRE-ECLAMPSIA |
1 |
0.0002 |
| 335 |
INJECTION SITE PAIN |
63 |
0.0002 |
| 336 |
INCORRECT DOSAGE ADMINISTERED |
1 |
0.0002 |
| 337 |
ACUTE KIDNEY INJURY |
31 |
0.0002 |
| 338 |
MATERNAL EXPOSURE DURING PREGNANCY |
18 |
0.0002 |
| 339 |
INABILITY TO AFFORD MEDICATION |
2 |
0.0002 |
| 340 |
ABDOMINAL TENDERNESS |
1 |
0.0002 |
| 341 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
1 |
0.0002 |
| 342 |
OSTEOPENIA |
3 |
0.0002 |
| 343 |
DRUG RESISTANCE |
5 |
0.0002 |
| 344 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
5 |
0.0002 |
| 345 |
FOETAL DEATH |
1 |
0.0002 |
| 346 |
TENDERNESS |
2 |
0.0002 |
| 347 |
RHABDOMYOLYSIS |
8 |
0.0002 |
| 348 |
BONE DENSITY DECREASED |
6 |
0.0002 |
| 349 |
INJECTION SITE DISCOMFORT |
2 |
0.0002 |
| 350 |
ANAL FISTULA |
1 |
0.0002 |
| 351 |
COMPRESSION FRACTURE |
1 |
0.0002 |
| 352 |
INJECTION SITE DISCHARGE |
1 |
0.0002 |
| 353 |
ANAL ABSCESS |
1 |
0.0002 |
| 354 |
SKIN LACERATION |
2 |
0.0002 |
| 355 |
TIC |
1 |
0.0002 |
| 356 |
TRANSAMINASES INCREASED |
4 |
0.0002 |
| 357 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 358 |
INTRACRANIAL PRESSURE INCREASED |
1 |
0.0002 |
| 359 |
ANGIOPATHY |
1 |
0.0002 |
| 360 |
ACUTE PULMONARY OEDEMA |
1 |
0.0002 |
| 361 |
EXPOSURE DURING PREGNANCY |
11 |
0.0002 |
| 362 |
PREMATURE LABOUR |
1 |
0.0002 |
| 363 |
CIRCULATORY COLLAPSE |
3 |
0.0002 |
| 364 |
VENTRICULAR SEPTAL DEFECT |
1 |
0.0002 |
| 365 |
HYPERTONIA |
1 |
0.0002 |
| 366 |
BLOOD URIC ACID INCREASED |
1 |
0.0002 |
| 367 |
HYPERVENTILATION |
1 |
0.0002 |
| 368 |
SKIN WARM |
1 |
0.0002 |
| 369 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 370 |
URINE ODOUR ABNORMAL |
1 |
0.0002 |
| 371 |
INJECTION SITE VESICLES |
1 |
0.0002 |
| 372 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
3 |
0.0002 |
| 373 |
DRUG ADMINISTRATION ERROR |
5 |
0.0002 |
| 374 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
0.0002 |
| 375 |
ABASIA |
4 |
0.0002 |
| 376 |
DRUG-INDUCED LIVER INJURY |
5 |
0.0002 |
| 377 |
BLEPHAROSPASM |
1 |
0.0002 |
| 378 |
SCREAMING |
1 |
0.0002 |
| 379 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
1 |
0.0002 |
| 380 |
ANAPHYLACTIC SHOCK |
4 |
0.0002 |
| 381 |
INFLAMMATION |
8 |
0.0002 |
| 382 |
TENDON DISORDER |
1 |
0.0002 |
| 383 |
NODULE |
2 |
0.0002 |
| 384 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 385 |
PULMONARY CONGESTION |
2 |
0.0002 |
| 386 |
PRODUCT FORMULATION ISSUE |
1 |
0.0002 |
| 387 |
JAUNDICE |
4 |
0.0001 |
| 388 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 389 |
UVEITIS |
2 |
0.0001 |
| 390 |
TACHYPNOEA |
2 |
0.0001 |
| 391 |
DEVICE DELIVERY SYSTEM ISSUE |
4 |
0.0001 |
| 392 |
HAEMATURIA |
5 |
0.0001 |
| 393 |
HOT FLUSH |
11 |
0.0001 |
| 394 |
CENTRAL NERVOUS SYSTEM LESION |
2 |
0.0001 |
| 395 |
RESPIRATORY DISTRESS |
4 |
0.0001 |
| 396 |
TOOTH LOSS |
3 |
0.0001 |
| 397 |
LYMPHOEDEMA |
1 |
0.0001 |
| 398 |
AUTOIMMUNE HEPATITIS |
1 |
0.0001 |
| 399 |
MASS |
2 |
0.0001 |
| 400 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 401 |
HAND FRACTURE |
1 |
0.0001 |
| 402 |
THERMAL BURN |
1 |
0.0001 |
| 403 |
LEUKOPENIA |
7 |
0.0001 |
| 404 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
4 |
0.0001 |
| 405 |
NO ADVERSE EVENT |
25 |
0.0001 |
| 406 |
MEDICAL DEVICE COMPLICATION |
1 |
0.0001 |
| 407 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 408 |
HYDRONEPHROSIS |
1 |
0.0001 |
| 409 |
PANCREATITIS |
7 |
0.0001 |
| 410 |
CONTRAINDICATED PRODUCT ADMINISTERED |
4 |
0.0001 |
| 411 |
SKIN DISCOLOURATION |
6 |
0.0001 |
| 412 |
DEVICE PHYSICAL PROPERTY ISSUE |
1 |
0.0001 |
| 413 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 414 |
TENDONITIS |
2 |
0.0001 |
| 415 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 416 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 417 |
FURUNCLE |
1 |
0.0001 |
| 418 |
DISEASE RECURRENCE |
6 |
0.0001 |
| 419 |
PNEUMOTHORAX |
2 |
0.0001 |
| 420 |
PREMATURE DELIVERY |
2 |
0.0001 |
| 421 |
TRANSPLANT REJECTION |
1 |
0.0001 |
| 422 |
HYPONATRAEMIA |
7 |
0.0001 |
| 423 |
SENSORY LOSS |
1 |
0.0001 |
| 424 |
MUSCLE INJURY |
1 |
0.0001 |
| 425 |
COAGULOPATHY |
2 |
0.0001 |
| 426 |
ATRIAL SEPTAL DEFECT |
1 |
0.0001 |
| 427 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 428 |
ANURIA |
1 |
0.0001 |
| 429 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 430 |
RASH MACULAR |
4 |
0.0001 |
| 431 |
URINE OUTPUT DECREASED |
1 |
0.0001 |
| 432 |
TUMOUR LYSIS SYNDROME |
1 |
0.0001 |
| 433 |
HYPOXIA |
4 |
0.0001 |
| 434 |
BLOOD TRIGLYCERIDES INCREASED |
2 |
0.0001 |
| 435 |
LYMPHADENOPATHY |
4 |
0.0001 |
| 436 |
INJECTION SITE ERYTHEMA |
14 |
0.0001 |
| 437 |
WRONG DRUG ADMINISTERED |
1 |
0.0001 |
| 438 |
HAEMARTHROSIS |
1 |
0.0001 |
| 439 |
DEVELOPMENTAL DELAY |
1 |
0.0001 |
| 440 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 441 |
OEDEMA |
6 |
0.0001 |
| 442 |
OPTIC NEURITIS |
1 |
0.0001 |
| 443 |
PATHOGEN RESISTANCE |
1 |
0.0001 |
| 444 |
HIDRADENITIS |
1 |
0.0001 |
| 445 |
SKIN IRRITATION |
5 |
0.0001 |
| 446 |
RESPIRATORY ARREST |
3 |
0.0001 |
| 447 |
MEDICATION ERROR |
6 |
0.0001 |
| 448 |
FEELING COLD |
3 |
0.0001 |
| 449 |
HYPERSENSITIVITY |
20 |
0.0001 |
| 450 |
NEPHROPATHY |
1 |
0.0001 |
| 451 |
PHOTOPHOBIA |
2 |
0.0001 |
| 452 |
ASTHMA |
12 |
0.0001 |
| 453 |
FOOT FRACTURE |
2 |
0.0001 |
| 454 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 455 |
SLEEP APNOEA SYNDROME |
2 |
0.0001 |
| 456 |
CHOLESTASIS |
2 |
0.0001 |
| 457 |
AFFECT LABILITY |
1 |
0.0001 |
| 458 |
PRESCRIBED OVERDOSE |
2 |
0.0001 |
| 459 |
LIVER FUNCTION TEST ABNORMAL |
3 |
0.0001 |
| 460 |
LOSS OF CONSCIOUSNESS |
13 |
0.0001 |
| 461 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 462 |
HYPOTONIA |
1 |
0.0001 |
| 463 |
SLUGGISHNESS |
1 |
0.0001 |
| 464 |
BODY TEMPERATURE INCREASED |
2 |
0.0001 |
| 465 |
EAR DISCOMFORT |
1 |
0.0001 |
| 466 |
UNINTENDED PREGNANCY |
1 |
0.0001 |
| 467 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 468 |
JOINT DISLOCATION |
1 |
0.0001 |
| 469 |
RENAL FAILURE ACUTE |
4 |
0.0001 |
| 470 |
METABOLIC ACIDOSIS |
3 |
0.0001 |
| 471 |
BODY HEIGHT DECREASED |
1 |
0.0001 |
| 472 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 473 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 474 |
MENSTRUATION DELAYED |
1 |
0.0001 |
| 475 |
PRODUCT DISPENSING ERROR |
2 |
0.0001 |
| 476 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
5 |
0.0001 |
| 477 |
EMOTIONAL DISTRESS |
11 |
0.0001 |
| 478 |
TOOTH FRACTURE |
1 |
0.0001 |
| 479 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
1 |
0.0001 |
| 480 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
2 |
0.0001 |
| 481 |
SKIN DISORDER |
3 |
0.0001 |
| 482 |
NERVE INJURY |
1 |
0.0001 |
| 483 |
SKIN INFECTION |
1 |
0.0001 |
| 484 |
NEPHROPATHY TOXIC |
1 |
0.0001 |
| 485 |
FISTULA |
1 |
0.0001 |
| 486 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
16 |
0.0001 |
| 487 |
EYE INFECTION |
1 |
0.0001 |
| 488 |
ERYTHEMA |
18 |
0.0001 |
| 489 |
GASTRIC DISORDER |
3 |
0.0001 |
| 490 |
TINNITUS |
4 |
0.0001 |
| 491 |
MUSCLE TWITCHING |
2 |
0.0001 |
| 492 |
CHEST PAIN |
16 |
0.0001 |
| 493 |
HYPERHIDROSIS |
11 |
0.0001 |
| 494 |
SPLENOMEGALY |
1 |
0.0001 |
| 495 |
BLOOD PRESSURE INCREASED |
13 |
0.0001 |
| 496 |
HOSPITALISATION |
13 |
0.0001 |
| 497 |
TREATMENT FAILURE |
7 |
0.0001 |
| 498 |
MUSCLE RIGIDITY |
1 |
0.0001 |
| 499 |
URTICARIA |
14 |
0.0001 |
| 500 |
LOCALISED INFECTION |
2 |
0.0001 |
| 501 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
3 |
0.0001 |
| 502 |
NEURALGIA |
2 |
0.0001 |
| 503 |
URINARY TRACT INFECTION |
14 |
0.0001 |
| 504 |
DISCOMFORT |
5 |
0.0001 |
| 505 |
CEREBRAL INFARCTION |
2 |
0.0001 |
| 506 |
FEELING HOT |
5 |
0.0001 |
| 507 |
INJECTION SITE EXTRAVASATION |
1 |
0.0001 |
| 508 |
TENDON RUPTURE |
1 |
0.0001 |
| 509 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
0.0001 |
| 510 |
ILEUS |
1 |
0.0001 |
| 511 |
SYNCOPE |
8 |
0.0001 |
| 512 |
CELLULITIS |
4 |
0.0001 |
| 513 |
BRAIN OEDEMA |
1 |
0.0001 |
| 514 |
CHRONIC KIDNEY DISEASE |
6 |
0.0001 |
| 515 |
HAEMATEMESIS |
2 |
0.0001 |
| 516 |
HEPATIC CYTOLYSIS |
1 |
0.0001 |
| 517 |
DEVICE DEPLOYMENT ISSUE |
1 |
0.0001 |
| 518 |
SEIZURE |
9 |
0.0001 |
| 519 |
ANOREXIA |
1 |
0.0001 |
| 520 |
GASTRITIS |
2 |
0.0001 |
| 521 |
ADVERSE REACTION |
1 |
0.0001 |
| 522 |
INJECTION SITE HAEMORRHAGE |
6 |
0.0001 |
| 523 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 524 |
LIMB INJURY |
2 |
0.0001 |
| 525 |
DRUG TOXICITY |
1 |
0.0001 |
| 526 |
OSTEOPOROSIS |
3 |
0.0001 |
| 527 |
CARDIAC ARREST |
6 |
0.0001 |
| 528 |
POLLAKIURIA |
3 |
0.0001 |
| 529 |
CARDIO-RESPIRATORY ARREST |
3 |
0.0001 |
| 530 |
WOUND |
2 |
0.0001 |
| 531 |
BLISTER |
4 |
0.0001 |
| 532 |
DEVICE OCCLUSION |
1 |
0.0001 |
| 533 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 534 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 535 |
DIALYSIS |
1 |
0.0001 |
| 536 |
PAIN |
43 |
0.0001 |
| 537 |
CONVULSION |
4 |
0.0001 |
| 538 |
PARALYSIS |
1 |
0.0001 |
| 539 |
ACCIDENTAL UNDERDOSE |
1 |
0.0001 |
| 540 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 541 |
SEPTIC SHOCK |
3 |
0.0001 |
| 542 |
HYPOKINESIA |
1 |
0.0001 |
| 543 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0001 |
| 544 |
URINARY INCONTINENCE |
2 |
0.0001 |
| 545 |
PULMONARY MASS |
1 |
0.0001 |
| 546 |
PYREXIA |
23 |
0.0001 |
| 547 |
DEVICE FAILURE |
1 |
0.0001 |
| 548 |
DRUG DISPENSING ERROR |
1 |
0.0001 |
| 549 |
EPILEPSY |
2 |
0.0001 |
| 550 |
ALANINE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
| 551 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 552 |
UPPER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 553 |
PRODUCT USE IN UNAPPROVED INDICATION |
16 |
0.0001 |
| 554 |
RASH |
28 |
0.0001 |
| 555 |
SWOLLEN TONGUE |
2 |
0.0001 |
| 556 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 557 |
OCULAR HYPERAEMIA |
3 |
0.0001 |
| 558 |
DYSPHAGIA |
6 |
0.0001 |
| 559 |
HALLUCINATION, AUDITORY |
1 |
0.0001 |
| 560 |
SCIATICA |
1 |
0.0001 |
| 561 |
ABSCESS |
1 |
0.0001 |
| 562 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 563 |
INTERSTITIAL LUNG DISEASE |
3 |
0.0001 |
| 564 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 565 |
STAPHYLOCOCCAL INFECTION |
2 |
0.0001 |
| 566 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 567 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 568 |
PSYCHOMOTOR HYPERACTIVITY |
1 |
0.0001 |
| 569 |
HYPOAESTHESIA |
9 |
0.0001 |
| 570 |
GAIT INABILITY |
2 |
0.0001 |
| 571 |
FACE OEDEMA |
1 |
0.0001 |
| 572 |
SKIN EXFOLIATION |
5 |
0.0001 |
| 573 |
CANDIDA INFECTION |
1 |
0.0001 |
| 574 |
METRORRHAGIA |
1 |
0.0001 |
| 575 |
HAEMOGLOBIN DECREASED |
6 |
0.0001 |
| 576 |
SCAR |
1 |
0.0001 |
| 577 |
PARANOIA |
1 |
0.0001 |
| 578 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 579 |
DEVICE DEFECTIVE |
1 |
0.0001 |
| 580 |
DEVICE USE ERROR |
2 |
0.0001 |
| 581 |
GAIT DISTURBANCE |
11 |
0.0001 |
| 582 |
EOSINOPHILIA |
1 |
0.0001 |
| 583 |
BURNING SENSATION |
4 |
0.0001 |
| 584 |
HYPERKALAEMIA |
2 |
0.0001 |
| 585 |
HEART RATE DECREASED |
2 |
0.0001 |
| 586 |
COLD SWEAT |
1 |
0.0001 |
| 587 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
4 |
0.0001 |
| 588 |
ANXIETY |
16 |
0.0001 |
| 589 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 590 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
2 |
0.0001 |
| 591 |
SYNOVITIS |
1 |
0.0001 |
| 592 |
CRYING |
2 |
0.0001 |
| 593 |
C-REACTIVE PROTEIN INCREASED |
2 |
0.0001 |
| 594 |
BONE DISORDER |
1 |
0.0001 |
| 595 |
PANIC ATTACK |
2 |
0.0001 |
| 596 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 597 |
NASOPHARYNGITIS |
10 |
0.0001 |
| 598 |
TREMOR |
9 |
0.0001 |
| 599 |
THINKING ABNORMAL |
1 |
0.0001 |
| 600 |
OXYGEN SATURATION DECREASED |
3 |
0.0001 |
| 601 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 602 |
GASTRIC ULCER |
1 |
0.0001 |
| 603 |
INCORRECT DOSE ADMINISTERED |
12 |
0.0001 |
| 604 |
FEELING JITTERY |
1 |
0.0001 |
| 605 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 606 |
DYSTONIA |
1 |
0.0001 |
| 607 |
EAR PAIN |
1 |
0.0001 |
| 608 |
OFF LABEL USE |
45 |
0.0001 |
| 609 |
CHILLS |
6 |
0.0001 |
| 610 |
SKIN FISSURES |
1 |
0.0001 |
| 611 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
0.0001 |
| 612 |
HEART RATE INCREASED |
5 |
0.0001 |
| 613 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 614 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 615 |
CARDIAC FAILURE |
4 |
0.0000 |
| 616 |
INTENTIONAL SELF-INJURY |
1 |
0.0000 |
| 617 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 618 |
STOMATITIS |
3 |
0.0000 |
| 619 |
PLEURAL EFFUSION |
3 |
0.0000 |
| 620 |
DYSKINESIA |
2 |
0.0000 |
| 621 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 622 |
PRODUCT USE ISSUE |
9 |
0.0000 |
| 623 |
DERMATITIS |
1 |
0.0000 |
| 624 |
RENAL IMPAIRMENT |
4 |
0.0000 |
| 625 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 626 |
ABDOMINAL PAIN |
11 |
0.0000 |
| 627 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 628 |
DEVICE LEAKAGE |
2 |
0.0000 |
| 629 |
BLOOD CREATININE INCREASED |
3 |
0.0000 |
| 630 |
PRODUCT STORAGE ERROR |
4 |
0.0000 |
| 631 |
MUSCULOSKELETAL STIFFNESS |
4 |
0.0000 |
| 632 |
FEBRILE NEUTROPENIA |
3 |
0.0000 |
| 633 |
RENAL FAILURE |
6 |
0.0000 |
| 634 |
LIVER DISORDER |
2 |
0.0000 |
| 635 |
HEPATOTOXICITY |
1 |
0.0000 |
| 636 |
GLOSSODYNIA |
1 |
0.0000 |
| 637 |
THROAT IRRITATION |
2 |
0.0000 |
| 638 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 639 |
CHROMATURIA |
1 |
0.0000 |
| 640 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 641 |
HEPATIC ENZYME INCREASED |
3 |
0.0000 |
| 642 |
INJECTION SITE REACTION |
3 |
0.0000 |
| 643 |
GENERAL PHYSICAL HEALTH DETERIORATION |
5 |
0.0000 |
| 644 |
COGNITIVE DISORDER |
2 |
0.0000 |
| 645 |
SWELLING |
4 |
0.0000 |
| 646 |
PALPITATIONS |
5 |
0.0000 |
| 647 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 648 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 649 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 650 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 651 |
INFECTION |
6 |
0.0000 |
| 652 |
DRUG INTOLERANCE |
4 |
0.0000 |
| 653 |
RESPIRATORY FAILURE |
3 |
0.0000 |
| 654 |
FIBROMYALGIA |
1 |
0.0000 |
| 655 |
PRESYNCOPE |
1 |
0.0000 |
| 656 |
UNDERDOSE |
3 |
0.0000 |
| 657 |
OEDEMA PERIPHERAL |
5 |
0.0000 |
| 658 |
AGITATION |
3 |
0.0000 |
| 659 |
LUNG DISORDER |
2 |
0.0000 |
| 660 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 661 |
DIARRHOEA |
26 |
0.0000 |
| 662 |
HALLUCINATION |
3 |
0.0000 |
| 663 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 664 |
FLUID RETENTION |
2 |
0.0000 |
| 665 |
ILLNESS |
4 |
0.0000 |
| 666 |
ACCIDENTAL EXPOSURE TO PRODUCT |
4 |
0.0000 |
| 667 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 668 |
HAEMATOMA |
1 |
0.0000 |
| 669 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 670 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
0.0000 |
| 671 |
DIPLOPIA |
1 |
0.0000 |
| 672 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 673 |
PSORIASIS |
5 |
0.0000 |
| 674 |
HEADACHE |
24 |
0.0000 |
| 675 |
NERVOUSNESS |
2 |
0.0000 |
| 676 |
HAEMORRHAGE |
4 |
0.0000 |
| 677 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
0.0000 |
| 678 |
PARAESTHESIA |
6 |
0.0000 |
| 679 |
DIZZINESS |
19 |
0.0000 |
| 680 |
DEPRESSED MOOD |
2 |
0.0000 |
| 681 |
DRUG INTERACTION |
6 |
0.0000 |
| 682 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 683 |
FEELING ABNORMAL |
9 |
0.0000 |
| 684 |
DEHYDRATION |
5 |
0.0000 |
| 685 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 686 |
PAIN IN EXTREMITY |
11 |
0.0000 |
| 687 |
PAIN OF SKIN |
1 |
0.0000 |
| 688 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 689 |
RASH PRURITIC |
2 |
0.0000 |
| 690 |
PRODUCT QUALITY ISSUE |
5 |
0.0000 |
| 691 |
NEUTROPENIA |
5 |
0.0000 |
| 692 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 693 |
GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0000 |
| 694 |
INFLUENZA |
4 |
0.0000 |
| 695 |
HAEMOPTYSIS |
1 |
0.0000 |
| 696 |
PANCYTOPENIA |
2 |
0.0000 |
| 697 |
MYALGIA |
6 |
0.0000 |
| 698 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 699 |
BACK PAIN |
8 |
0.0000 |
| 700 |
INTENTIONAL PRODUCT MISUSE |
3 |
0.0000 |
| 701 |
DYSPHONIA |
2 |
0.0000 |
| 702 |
HEPATIC FAILURE |
1 |
0.0000 |
| 703 |
APHASIA |
1 |
0.0000 |
| 704 |
INJECTION SITE RASH |
1 |
0.0000 |
| 705 |
FEMUR FRACTURE |
1 |
0.0000 |
| 706 |
ASTHENIA |
12 |
0.0000 |
| 707 |
VOMITING |
15 |
0.0000 |
| 708 |
NEUROPATHY PERIPHERAL |
3 |
0.0000 |
| 709 |
CYSTITIS |
1 |
0.0000 |
| 710 |
ARTHRALGIA |
13 |
0.0000 |
| 711 |
CONTUSION |
3 |
0.0000 |
| 712 |
RHINORRHOEA |
2 |
0.0000 |
| 713 |
SWELLING FACE |
2 |
0.0000 |
| 714 |
CHOLELITHIASIS |
1 |
0.0000 |
| 715 |
IMPAIRED HEALING |
1 |
0.0000 |
| 716 |
EYE DISORDER |
1 |
0.0000 |
| 717 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 718 |
LIP SWELLING |
1 |
0.0000 |
| 719 |
URINARY RETENTION |
1 |
0.0000 |
| 720 |
HYPOTENSION |
6 |
0.0000 |
| 721 |
MALAISE |
13 |
0.0000 |
| 722 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 723 |
DRUG EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 724 |
DELIRIUM |
1 |
0.0000 |
| 725 |
INJURY |
2 |
0.0000 |
| 726 |
DYSPNOEA |
16 |
0.0000 |
| 727 |
PNEUMONIA |
9 |
0.0000 |
| 728 |
MYELOSUPPRESSION |
1 |
0.0000 |
| 729 |
DYSURIA |
1 |
0.0000 |
| 730 |
EPISTAXIS |
2 |
0.0000 |
| 731 |
DYSARTHRIA |
1 |
0.0000 |
| 732 |
ACNE |
2 |
0.0000 |
| 733 |
ANAEMIA |
5 |
0.0000 |
| 734 |
PRURITUS |
10 |
0.0000 |
| 735 |
PERIPHERAL SWELLING |
4 |
0.0000 |
| 736 |
INJECTION SITE BRUISING |
2 |
0.0000 |
| 737 |
DRUG INEFFECTIVE |
33 |
0.0000 |
| 738 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 739 |
VISUAL IMPAIRMENT |
3 |
0.0000 |
| 740 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 741 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 742 |
FATIGUE |
18 |
0.0000 |
| 743 |
CONDITION AGGRAVATED |
7 |
0.0000 |
| 744 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 745 |
COVID-19 |
4 |
0.0000 |
| 746 |
ANGIOEDEMA |
1 |
0.0000 |
| 747 |
TACHYCARDIA |
2 |
0.0000 |
| 748 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 749 |
DEVICE ISSUE |
2 |
0.0000 |
| 750 |
VISION BLURRED |
3 |
0.0000 |
| 751 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 752 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 753 |
RENAL DISORDER |
1 |
0.0000 |
| 754 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |
0.0000 |
| 755 |
COUGH |
6 |
0.0000 |
| 756 |
ARRHYTHMIA |
1 |
0.0000 |
| 757 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 758 |
NAUSEA |
16 |
0.0000 |
| 759 |
FLUSHING |
2 |
0.0000 |
| 760 |
ABDOMINAL PAIN UPPER |
4 |
0.0000 |
| 761 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 762 |
SPEECH DISORDER |
1 |
0.0000 |
| 763 |
DERMATITIS ATOPIC |
1 |
0.0000 |
| 764 |
BRADYCARDIA |
1 |
0.0000 |
| 765 |
ARTHROPATHY |
1 |
0.0000 |
| 766 |
SEPSIS |
2 |
0.0000 |
| 767 |
THROMBOCYTOPENIA |
2 |
0.0000 |
| 768 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 769 |
DEPRESSION |
4 |
0.0000 |
| 770 |
DEATH |
15 |
0.0000 |
| 771 |
BONE PAIN |
1 |
0.0000 |
| 772 |
SURGERY |
1 |
0.0000 |
| 773 |
NASAL CONGESTION |
1 |
0.0000 |
| 774 |
WHEEZING |
1 |
0.0000 |
| 775 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 776 |
AMNESIA |
1 |
0.0000 |
| 777 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 778 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
3 |
0.0000 |
| 779 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 780 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 781 |
HYPERTENSION |
3 |
0.0000 |
| 782 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 783 |
MOBILITY DECREASED |
1 |
0.0000 |
| 784 |
BRONCHITIS |
1 |
0.0000 |
| 785 |
DYSGEUSIA |
1 |
0.0000 |
| 786 |
DIABETES MELLITUS |
1 |
0.0000 |
| 787 |
DECREASED APPETITE |
3 |
0.0000 |
| 788 |
ARTHRITIS |
1 |
0.0000 |
| 789 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 790 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 791 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 792 |
DRUG DOSE OMISSION |
2 |
0.0000 |
| 793 |
FALL |
4 |
0.0000 |
| 794 |
DRUG ABUSE |
1 |
0.0000 |
| 795 |
COMPLETED SUICIDE |
1 |
0.0000 |
| 796 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 797 |
BALANCE DISORDER |
1 |
0.0000 |
| 798 |
INSOMNIA |
3 |
0.0000 |
| 799 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 800 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 801 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 802 |
MUSCLE SPASMS |
2 |
0.0000 |
| 803 |
ADVERSE EVENT |
1 |
0.0000 |
| 804 |
CARDIAC DISORDER |
1 |
0.0000 |
| 805 |
MIGRAINE |
1 |
0.0000 |
| 806 |
SOMNOLENCE |
2 |
0.0000 |
| 807 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 808 |
SINUSITIS |
1 |
0.0000 |
| 809 |
CONSTIPATION |
2 |
0.0000 |
| 810 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 811 |
JOINT SWELLING |
1 |
0.0000 |
| 812 |
WEIGHT DECREASED |
2 |
0.0000 |
| 813 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 814 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 815 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 816 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 817 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 818 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 819 |
OVERDOSE |
1 |
0.0000 |
| 820 |
WEIGHT INCREASED |
1 |
0.0000 |